HOME > Exhibitior Search > Search by Exhibitor

Search by Exhibitor(2024)

Search
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Exhibitors registered total : 33 companies

Search by Exhibitor

Keyword :

Accuprec Research Labs Pvt. Ltd.

Read more

EH102

www.accuprec.com

91-9099981023

Description

Accuprec Research Labs Pvt. Ltd. is FDCA, FDCA-GLP, OECD-GLP, AAALAC, CCSEA, ISO 9001:2015, NABL, ISO/IEC 17025, AYUSH, DSIR, CDSCO, DUNS, FDCA-Cos, CIBRC & USFDA approved Contract Research Organisation (CRO) having Head Quarter at Ahmedabad, Gujarat and having branch offices at Sudbury, Canada and Pennsylvania, USA. Accuprec is a service provider for various testing services required for pharmaceuticals, chemicals, phytochemicals, herbal formulations, food and Medical devices. Currently we are working as an extended partner for more than 1000+ companies in India as well as international level also."

Item discription

ACMEDI KOREA CO.,LTD

Read more

A405

www.acmedikorea.com

070-8688-3884

Description

ACMEDI KOREA Co.,Ltd located in Seoul, is a company that exports specialized medical device, cosmetics and medicines used in beauty clinics and dermatology. We are dealing with Dermal fillers, HA body fillers, Lifting Threads, Meso solutions, Slimming solutions, Plasma devices and etc. Major exporting countries include Thailand, CIS, Vietnam, Kuwait and South American countries. May, 2015- Established company name to Acmedi Korea Co., Ltd (Cooperate Taxpayer) Aug, 2018- Approved as a Medical Device Manufacturing Company Sep, 2018- Acquired ISO 9001 and ISO 13485 for Vegaplax and Plamon Jan, 2019- Awarded $ 5 Million Export Tower by KITA Apr, 2019- Designated as a "Small Giant Company" of Korea Jan, 2021- Designated as "Hi-Seoul Company" by SEOUL MG Feb, 2021- Awarded $ 7 Million Export Tower by KITA Mar, 2021 - Acquired CPNP( VellaPair) May, 2021 - Acquired CE MDD (VegaPlax)

Item discription

Hyaluronic Acid Dermal Filler Brand : Dermaren, Divineus, Philos, Helene, Dermaren lumi seriesr

ADAPTER TECHNOLOGY CO., LTD

Read more

Description

Adapter Technology Co. Ltd. was founded in 2001 and it has become a promising and growing enterprise with design ability in the Power Supply Manufacturing industry. We dedicate to providing reliable quality, flexible service and upgrading technology to meet customer’s requests. Our product line covers I.T.E., medical, industrial applications, and chargers. With a strong R&D team’s support, we can custom design according to each different specification and provide the best solution to customers.

Item discription

* IEC/EN/ANSI/AAMI ES60601-1 (Edition 3.2) * EMC: IEC60601-1-2 (Edition 4.1) * IEC/EN/UL 62368-1 3rd Edition * 100-240VAC Universal Input * Gallium Nitride Based Design * Means of Protection: 2 X MOPP * Touch Current: < 100μA * Efficiency up to 95% * Regulated Output with Low Ripple Noise * Modified and Custom Designs Available * 2 Years Warranty

ADDPLUS Co.,Ltd

Read more

B220

www.add-plus.co.kr

053-793-1001

Description

Item discription

AesMed Co., Ltd.

Read more

B715

www.aesmed.co.kr

02-444-0889

Description

AesMed Co., Ltd. is a cosmetics, medical device manufacturer and sales company specializing in hair loss treatment, which has been leading the issue in the domestic and foreign hair loss markets for the past 22 years. Currently, we provide products to 7 university hospitals, 500 hospitals, clinics, and major hair transplant centers, and so far, 3 million procedures have been performed with Aesmed’s AGF39. AGF39 was developed in 2008. The cytokine therapy for alopecia with AGF39 is now accepted as a standard of mesotherapy solution for alopecia treatment. In addition, the research results were introduced and published in the SCI Journal and the World Congress for Hair Research. (SCI Journal, Journal of Dermatology 2012:39:1-2 / World Congress for hair research 2013, Edinburgh, Scotland p056. / World congress for hair research 2014, Jeju, Korea p180.) AGF39 is getting widely noted to the world by academic exchanges in medical alopecia field as an essential method for the treatment.

Item discription

PP Cream_Posrt procedure cream protects and improves the skin environment Quality - Strong 5-moisturizing ingredients - Minimize surfactants - Use breathable polymer silicon base - Room temperature emulsification process to maintain active ingredient activity. - No harmful ingredients: Harmful preservatives, acne-causing ingredients, incense & pigment - KFDA-certified functional cosmetic for whitening

AGNES MEDICAL CO., LTD.

Read more

A436

www.agnesmedical.com

031-8020-9721

Description

Company Name: Agnes Medical Co., Ltd. Signature device: AGNES, DoubleTite Agnes Medical Co., ltd. manufactures medical devices based on Radio Frequency technology which is stable and very effective. The Signature device, AGNES RF, focuses Radio Frequency energy on the target tissue in consideration of the anatomical structure of the skin for treatment. Using micro-insulating needles, the epidermal layer is protected and applied widely to the target layer, delivering sufficient energy to destroy certain tissues such as sebaceous glands and the fat. Needles designed based on anatomy for each treatment indication enhance the treatment effect and increase the reproducibility of treatment. Through years of ceaseless efforts to provide innovative and reliable answers to doctors and patients, Agnes Medical Co., Ltd. has become one of the most dynamic and innovative providers of RF energy-based beauty and medical systems. Our mission is to supply the systems and treatment

Item discription

DoubleTite is By simultaneously delivering RF energy to the Papillary and Reticular Dermis, It effectively regenerates collagen and elastic fibers throughout the dermis layer to improve skin elasticity. In addition, you can experience a synergistic effect by injecting skin booster suitable for your skin type. Although DoubleTite is an invasive treatment using needles, there is almost no downtime and less pain.

AI Medic Inc.

Read more

BL116

aimedic.kr

02-568-2667

Description

AI Medic is a company that develops cardiovascular diagnosis and treatment assistance technology based on CT image-based simulation. HeartMedi+ provides CT-FFR non-invasively for patients with a 40% to 90% stenosis rate. AutoSeg also provides comprehensive essential factors for diagnosing heart diseases, such as segmentation of coronary arteries, atria, ventricles and aortic valves, and calcium scoring and plaque analysis.

Item discription

Provides auto-segmentation of coronary, cardiac and various analysis functions based on CT images.

AIinsight.INC

Read more

C634

aiinsight.io

032-719-7420

Description

With the recent designation of WISKY as an innovative medical device, it is a technology that has both stability and potential It's been evaluated. WISKY is capable of diagnosing three major blindness diseases: diabetic retinopathy, glaucoma, and macular degeneration With software, the three major blindness diseases do not have pain or symptoms, so if the outbreak is confirmed, treatment is delayed It could soon lead to blindness. WISKY could immediately produce results for the three major blindness diseases in one minute after the fundus scan It can be seen. It can help slow down or prevent blindness

Item discription

With the recent designation of WISKY as an innovative medical device, it is a technology that has both stability and potential It's been evaluated. WISKY is capable of diagnosing three major blindness diseases: diabetic retinopathy, glaucoma, and macular degeneration With software, the three major blindness diseases do not have pain or symptoms, so if the outbreak is confirmed, treatment is delayed It could soon lead to blindness. WISKY could immediately produce results for the three major blindness diseases in one minute after the fundus scan It can be seen. It can help slow down or prevent blindness

Ailee Co., Ltd.

Read more

B145

www.ailee.kr

051-322-6161

Description

Dear Sir or Madam All Ailee sutures and needles are Korean made since 1963. Ailee is a manufacturer of suture, needle, and surgical scalpels for about 59 years, and holds about 40% market share in the Korean suture market. We have developed product quality through consistent investment in R&D while competing with multinational corporations. As a result, we are confident that we have the best quality and manufacturing techniques. Also, by participating in prestige overseas exhibitions and overseas expansion, we were recognized as one of the best manufacturers by numerous buyers thanks to our product quality and performance. One of our strengths is that our products are produced manually by highly skilled Koreans with an average working year of over 20 years. Also, the examination is carried out in every production process. Lastly, we are able to customize the products according to customers' specific needs. We are looking for a potential partner to share our vision.

Item discription

This suture, which is produced by applying biodegradable Poly(p-dioxanone) to the thread, creating barbs, and attaching needle, is a disposable product for use in general soft tissue appoximation and/or ligation. Barbedfit is a synthetic absorbable mono-filament suture made from Poly dioxanone which can be fully absorbed within 180~240 days. COLOUR : Violet STERILIZATION : Ethylene Oxide SIZE : USP 4/0 ~ 2 EP 1.5 ~ 5 % of original strength remaining 2 Weeks : 85% 3 Weeks : 82% 4 Weeks : 80% CERTIFICATION Certificate of GMP (KGMP) ISO 9001 ISO 14001 ISO 13485

AITRICS

Read more

C105

www.aitrics.com

02-569-5507

Description

"Can AI save people's lives?" AITRICS started up with this question. If we can overcome healthcare limitations with AI technology, we can provide better medical services to a greater number of people. Based on its outstanding vital sign technology, AITRICS performs remarkably well at various international AI conferences every year and is recognized worldwide for its technology. Currently, AITRICS possesses a team of dedicated AI research professionals, producing reliable products. The company collaborates with in-house medical experts and top-tier hospitals both domestically and internationally to enhance its expertise and train models based on high-quality medical data. In the future, AITRICS aims to expand the application of its developed AITRICS-VC (VitalCare) to additional hospital wards and a broader range of medical conditions. The company also seeks to extend its reach to remote patients and the general public outside of hospital settings.

Item discription

VitalCare is an AI-based medical device that monitors patient's condition in real-time in hospitals and predicts the risk of deterioration at an early stage. VitalCare predicts ▲Sepsis risk in GW within 4 hours ▲risk of MAES(Mortality, Unexpected ICU Transfer, CPR) and ▲Mortality risk in ICU within 6 hours through analyzing EMR data. The accurate early prediction of events by VitalCare supports timely treatment of patients, increasing the possibility of successful treatment, and enables efficient workflow for HCPs. VitalCare was approved by MFDS in Oct. 2022. And it was designated as the breakthrough device by MFDS in Dec. of the same year. Following the designation as conditional nHTA by MOHW, it has been used as a non-reimburable medical device in clinical sites since Mar. 1, 2023. VitalCare is being introduced in numerous domestic hospitals including Gangnam Severance Hospital, Korea University Anam Hospital and Konkuk University Medical Center.